Literature DB >> 6278189

Calorie restriction: effect on growth of human tumors heterotransplanted in nude mice.

B C Giovanella, R C Shepard, J S Stehlin, J M Venditti, B J Abbott.   

Abstract

The presence of 4 human malignant tumors (1 breast, 1 lung, and 2 colon carcinomas) growing subcutaneously as heterotransplants in nude mice did not significantly affect the body weights of adult animals until the tumors reached very large dimensions (tumor wt greater than 15% of the body wt). However, a colon carcinoma (HT 29) induced a cessation of the natural rate of body weight increase when it grew in young adults (animals weighing approximately equal to 25 g which will gain 6 g or approximately equal to 25% body wt in 1 mo). Calorie restriction at all the levels tested (8, 6, 4, and 2 g/day/mouse) with standard pelletized mouse food produced both weight loss in the animals (with and without tumor) and a lowering of the growth rate of all the 4 tumors tested growing at a subcutaneous site and/or under the kidney capsule. Each tumor responded differently to the calorie restriction. The 4 tumors tested grew equally in both male and female nude mice. Young animals weighing 20 g inoculated with a fifth tumor (MeWo melanoma) exhibited tumor growth inhibition proportional to restriction of calorie intake. Their survival, however, did not improve.

Entities:  

Mesh:

Year:  1982        PMID: 6278189

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

Review 1.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 2.  Translational approaches to addressing complex genetic pathways in colorectal cancer.

Authors:  Dayna S Early; Luigi Fontana; Nicholas O Davidson
Journal:  Transl Res       Date:  2007-10-04       Impact factor: 7.012

Review 3.  Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

Authors:  Kenneth W Hance; Connie J Rogers; Stephen D Hursting; John W Greiner
Journal:  Front Biosci       Date:  2007-09-01

4.  Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.

Authors:  L H Li; R C Kelly; M A Warpehoski; J P McGovren; I Gebhard; T F DeKoning
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

Review 5.  Considerations in the use of nude mice for cancer research.

Authors:  F E Sharkey; J Fogh
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.

Authors:  C A Kristensen; N Askenasy; R K Jain; A P Koretsky
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

7.  Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression.

Authors:  Susan E Olivo-Marston; Stephen D Hursting; Susan N Perkins; Aaron Schetter; Mohammed Khan; Carlo Croce; Curtis C Harris; Jackie Lavigne
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  ERGO: a pilot study of ketogenic diet in recurrent glioblastoma.

Authors:  Johannes Rieger; Oliver Bähr; Gabriele D Maurer; Elke Hattingen; Kea Franz; Daniel Brucker; Stefan Walenta; Ulrike Kämmerer; Johannes F Coy; Michael Weller; Joachim P Steinbach
Journal:  Int J Oncol       Date:  2014-04-11       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.